Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Jun 25, 2021

5250_rns_2021-06-25_2d2618ad-d843-42c8-8857-dd4f14dfde36.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - Willis Towers Watson plc

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 24 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,837,165 1.42% 240,530 0.19%
(2) Derivatives (other than options):
72,359 0.06% 202,408 0.16%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,915,624 1.49% 449,038 0.35%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 5 232.9200 USD
Purchase 5 232.9000 USD
Purchase 7 232.9300 USD
Purchase 16 232.3500 USD
Purchase 23 232.1300 USD
Purchase 102 232.9994 USD
Purchase 130 232.1400 USD
Purchase 200 232.3075 USD
Purchase 500 232.3200 USD
Purchase 699 232.6570 USD
Purchase 856 232.5444 USD
Purchase 948 232.1454 USD
Purchase 965 232.2944 USD
Purchase 1,112 232.6205 USD
Purchase 1,500 232.2144 USD
Purchase 1,740 232.4180 USD
Purchase 1,760 232.7513 USD
Purchase 1,814 232.5765 USD
Purchase 1,920 232.2497 USD
Purchase 1,999 232.4168 USD
Purchase 2,000 232.7322 USD
Purchase 2,507 232.4430 USD
Purchase 3,301 232.5683 USD
Purchase 4,075 232.5484 USD
Purchase 5,248 232.4241 USD
Purchase 5,277 232.1820 USD
Purchase 5,960 232.4471 USD
Purchase 6,643 232.7864 USD
Purchase 6,933 232.3602 USD
Purchase 10,369 232.5277 USD
Purchase 17,788 232.3398 USD
Purchase 21,038 232.8036 USD
Purchase 36,675 232.4745 USD
Purchase 109,954 232.5500 USD
Sale 2 232.8100 USD
Sale 7 232.9300 USD
Sale 10 232.6615 USD
Sale 18 232.7211 USD
Sale 40 232.8400 USD
Sale 87 233.0262 USD
Sale 92 232.7500 USD
Sale 100 232.8500 USD
Sale 102 232.5898 USD
Sale 200 232.8200 USD
Sale 206 232.5368 USD
Sale 219 232.8355 USD
Sale 260 232.6546 USD
Sale 305 232.7510 USD
Sale 385 232.5009 USD
Sale 451 232.8855 USD
Sale 500 232.3200 USD
Sale 540 232.4170 USD
Sale 657 232.5776 USD
Sale 921 232.4943 USD
Sale 1,076 232.9034 USD
Sale 1,110 232.6803 USD
Sale 1,168 232.8933 USD
Sale 1,687 232.7446 USD
Sale 1,984 232.1683 USD
Sale 2,018 232.4028 USD
Sale 2,231 232.3166 USD
Sale 2,515 232.6563 USD
Sale 4,075 232.5484 USD
Sale 4,326 232.3613 USD
Sale 5,590 232.8399 USD
Sale 7,630 232.3962 USD
Sale 8,268 232.7762 USD
Sale 9,169 232.7889 USD
Sale 9,970 232.3030 USD
Sale 10,000 231.9430 USD
Sale 10,368 232.5277 USD
Sale 55,850 232.5298 USD
Sale 108,450 232.5500 USD

(b) Derivatives transactions (other than options transactions)

Product Name Nature of transaction Number of relevant securities Price per
unit
SWAP Short 107,827 232.5500 USD

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 25 Jun 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210625005224/en/

BARCLAYS PLC